503 results on '"Jamieson, Nigel B"'
Search Results
2. The Surveillance Strategy for Intraductal Pancreatic Mucinous Neoplasms: Criteria for Discontinuation
3. Pancreatic cancer
4. NFκB signalling in colorectal cancer: Examining the central dogma of IKKα and IKKβ signalling
5. Evidence for molecular subtyping in pancreatic ductal adenocarcinoma: a systematic review
6. The relationship between heart rate variability and TNM stage, co-morbidity, systemic inflammation and survival in patients with primary operable colorectal cancer
7. Optimal surgical approach for digestive neuroendocrine neoplasia primaries: Oncological benefits versus short and long-term complications
8. Correction: Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
9. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
10. Pancreatic cancer
11. Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence
12. Pancreatic Cystic Lesions and Risk of Cancer
13. Immuno-Oncology in Pancreatic Cancer
14. Molecular Subtyping of Pancreatic Cancer
15. Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience
16. The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis
17. Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development
18. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
19. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer
20. RET gene rearrangements occur in a subset of pancreatic acinar cell carcinomas
21. Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy
22. Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position
23. Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage
24. The Relationship between Liver Volume, Clinicopathological Characteristics and Survival in Patients Undergoing Resection with Curative Intent for Non-Metastatic Colonic Cancer
25. Abstract A028: Multiomic modelling of pancreatic IPMN stroma reveals distinct tertiary lymphoid structure distribution: Mapping the transcriptomic landscape via regional bulk, single-cell and subcellular approaches
26. Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies distinct clinical subgroups.
27. Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors
28. Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies
29. Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy
30. Histopathologic Predictors of Survival and Recurrence in Resected Ampullary Adenocarcinoma: International Multicenter Cohort Study
31. Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer
32. Pancreatoduodenectomy With Arterial Resection for Locally Advanced Pancreatic Cancer of the Head: A Systematic Review
33. Hypermutation In Pancreatic Cancer
34. Management of post-pancreatectomy haemorrhage using resuscitative endovascular balloon occlusion of the aorta
35. Pseudobudding: ruptured glands do not represent true tumor buds
36. Pseudobudding: ruptured glands do not represent true tumor buds
37. Reply to Comment on “The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic”
38. Inflammatory Dysregulation and Cancer: From Molecular Mechanisms to Therapeutic Opportunities
39. Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation
40. Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal Adenocarcinoma
41. Transcriptomics and proteomics reveal distinct biology for lymph node metastases and tumour deposits in colorectal cancer
42. Transcriptomics and proteomics reveal distinct biology for lymph node metastases and tumour deposits in colorectal cancer.
43. Supplementry Table 3: REACTOME Gene Set Enrichment Analysis results from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
44. Supplementary Methods from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
45. Supplementary Table 4: SpatialDecon derived immune cell counts from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
46. Supplementary Data from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
47. Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
48. Data from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
49. Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy
50. Abstract 4691: Spatially resolved transcriptomics deconvolutes histological prognostic subgroups in patients with colorectal cancer and synchronous liver metastases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.